DK105391D0 - Et rent faktor i produkt og fremgangsmaade til fremstilling heraf - Google Patents

Et rent faktor i produkt og fremgangsmaade til fremstilling heraf

Info

Publication number
DK105391D0
DK105391D0 DK911053A DK105391A DK105391D0 DK 105391 D0 DK105391 D0 DK 105391D0 DK 911053 A DK911053 A DK 911053A DK 105391 A DK105391 A DK 105391A DK 105391 D0 DK105391 D0 DK 105391D0
Authority
DK
Denmark
Prior art keywords
factor
pct
procedure
manufacturing
product
Prior art date
Application number
DK911053A
Other languages
English (en)
Other versions
DK105391A (da
Inventor
Karin Oestergaard Alsoee
Jesper Kihl
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK105391A priority Critical patent/DK105391A/da
Publication of DK105391D0 publication Critical patent/DK105391D0/da
Publication of DK105391A publication Critical patent/DK105391A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK105391A 1988-12-20 1991-06-03 Et rent faktor i produkt og fremgangsmaade til fremstilling heraf DK105391A (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK105391A DK105391A (da) 1988-12-20 1991-06-03 Et rent faktor i produkt og fremgangsmaade til fremstilling heraf

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK708488A DK708488D0 (da) 1988-12-20 1988-12-20 Faktor i praeparat
PCT/DK1989/000297 WO1990006759A1 (en) 1988-12-20 1989-12-19 A pure factor i protein and a process for producing said protein
DK105391A DK105391A (da) 1988-12-20 1991-06-03 Et rent faktor i produkt og fremgangsmaade til fremstilling heraf

Publications (2)

Publication Number Publication Date
DK105391D0 true DK105391D0 (da) 1991-06-03
DK105391A DK105391A (da) 1991-06-03

Family

ID=8149208

Family Applications (2)

Application Number Title Priority Date Filing Date
DK708488A DK708488D0 (da) 1988-12-20 1988-12-20 Faktor i praeparat
DK105391A DK105391A (da) 1988-12-20 1991-06-03 Et rent faktor i produkt og fremgangsmaade til fremstilling heraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK708488A DK708488D0 (da) 1988-12-20 1988-12-20 Faktor i praeparat

Country Status (11)

Country Link
US (1) US5378811A (da)
EP (1) EP0449897B1 (da)
JP (1) JPH04502324A (da)
AT (1) ATE101521T1 (da)
AU (1) AU4811290A (da)
DE (1) DE68913212T2 (da)
DK (2) DK708488D0 (da)
ES (1) ES2062502T3 (da)
FI (1) FI95440C (da)
NO (1) NO912387D0 (da)
WO (1) WO1990006759A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
JP2002523336A (ja) * 1998-08-25 2002-07-30 アッシュ・メディカル・システムズ・インコーポレーテッド クエン酸塩カテーテルロック溶液を使用するカテーテル開存性を高める方法
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
GB0904427D0 (en) * 2009-03-13 2009-04-29 Lachmann Peter Treatment of diseases related to hyperactivity of the complement system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623717A (en) * 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
JPH0742235B2 (ja) * 1985-11-08 1995-05-10 三共株式会社 自己免疫性疾病の予防・治療剤

Also Published As

Publication number Publication date
ES2062502T3 (es) 1994-12-16
DK708488D0 (da) 1988-12-20
EP0449897B1 (en) 1994-02-16
NO912387L (no) 1991-06-19
DE68913212D1 (de) 1994-03-24
ATE101521T1 (de) 1994-03-15
FI95440B (fi) 1995-10-31
FI95440C (fi) 1996-02-12
WO1990006759A1 (en) 1990-06-28
NO912387D0 (no) 1991-06-19
AU4811290A (en) 1990-07-10
US5378811A (en) 1995-01-03
DE68913212T2 (de) 1994-05-19
JPH04502324A (ja) 1992-04-23
EP0449897A1 (en) 1991-10-09
DK105391A (da) 1991-06-03
FI912879A0 (fi) 1991-06-14

Similar Documents

Publication Publication Date Title
CA2034489A1 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
NO972451L (no) Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav
NO973685L (no) Multi-tumor avvikende vekstgener
ATE175873T1 (de) Weitere indolderivate mit antiviraler wirkung
DK0722344T3 (da) Fremgangsmåde til virusinaktivering i nærvær af en polyether og et middel
DK87891D0 (da) Polypeptid og dets anvendelse til fremstilling af et laegemiddel til behandling af thromboemboliske tilstande
SE8104482L (sv) Forfarande for framstellning av ett faktor viii (ahf)-hogkoncentrat
HU895788D0 (en) Process for producing peptides and medical products containing them
DK573587A (da) Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion
ATE211390T1 (de) Überlegende thrombomodulinanaloga zur pharmazeutischen verwendung
DK105391A (da) Et rent faktor i produkt og fremgangsmaade til fremstilling heraf
NO931413D0 (no) Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
ATE210184T1 (de) Ungespleisste varianten des gp350/220
NO175875C (no) Stöpt gjenstand av nikkelbasert superlegering, den nikkelbaserte superlegering som sådan, og varmebehandling av gjenstanden
EP0552257A4 (en) A plant protein useful for treating tumors and hiv infection
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ATE270333T1 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung
CA2096888A1 (en) Process for the inactivation of viruses in preparations of proteins
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
FR2694938B1 (fr) Nouveaux peptides, anticorps diriges contre ces peptides, anticorps anti-idiotypiques, application a titre de medicaments, compositions pharmaceutiques et kits de diagnostic les renfermant.